Antibiotics revolutionized health care when they were introduced in the early twentieth century, making many severe and often ...

Though Gilead Sciences made waves last June with a landmark FDA approval for its twice-yearly HIV preventive Yeztugo (lenacapavir), the first-in-class drug had previously been used as a long-acting ...

Despite effective suppression of viral replication by antiretroviral therapy (ART), chronic HIV infection remains characterized by persistent low-level inflammation and progressive tissue damage, ...

Giving adolescents living with HIV high-dose Vitamin D and calcium supplements can help improve their bone density and reduce the risk of fractures, a new study suggests. Sexual violence against ...

Since the human immunodeficiency virus (HIV) was identified in 1983, roughly 91.4 million people around the world have contracted the virus and an additional 44.1 million have died from related causes ...

Adoptive T-cell therapy has transformed the treatment landscape of several hematologic malignancies. However, patients living with HIV infection have been largely excluded from this progress.

HIV, the human immunodeficiency virus that can cause AIDS if left untreated, is much less of a transmission risk today than it was 20 years ago, thanks to public awareness about prevention (and ...

Health experts are sounding the alarm over a disturbing trend where drug users swap blood to score a secondhand high. Called “bluetoothing,” the gruesome movement is fueling a wave of new HIV ...

Add Yahoo as a preferred source to see more of our stories on Google. An image collage containing 3 images, Image 1 shows Close-up of a syringe needle injecting a young boy's arm, Image 2 shows A ...

Kenya has reversed a three-year downward trend in new HIV infections, with new cases rising sharply in 2024, according to data released by the National Syndemic Disease Control Council (NSDCC). The ...

The National Institutes of Health placed a big bet on Oregon scientist Jonah Sacha this week, awarding Sacha and his colleagues an $8.4 million, five-year grant for their work developing a cure for ...